Viewing Study NCT00105469


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-01-02 @ 2:09 AM
Study NCT ID: NCT00105469
Status: COMPLETED
Last Update Posted: 2013-12-16
First Post: 2005-03-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-07
Start Date Type: None
Primary Completion Date: 2005-10
Primary Completion Date Type: ACTUAL
Completion Date: 2005-10
Completion Date Type: ACTUAL
First Submit Date: 2005-03-14
First Submit QC Date: None
Study First Post Date: 2005-03-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-08-01
Results First Submit QC Date: None
Results First Post Date: 2011-10-27
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-11-21
Last Update Post Date: 2013-12-16
Last Update Post Date Type: ESTIMATED